ShenFu Injection for Myocardial Protection in Patients With Acute ST Segment Elevation Myocardial Infarction
Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether perioperative use of Shenfu Injection could
reduce myocardial injury (enzymatic infarct size and infarct volume according to cardiac
magnetic resonance imaging) in patients with STEMI after primary PCI
Phase:
Phase 4
Details
Lead Sponsor:
Beijing Anzhen Hospital
Collaborator:
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.